Source - RNS
RNS Number : 4576J
InnovaDerma PLC
09 September 2016
 

InnovaDerma PLC

("InnovaDerma" or the "Company")

 

VOLUNTARY SUSPENSION OF TRADING ON MARCHÉ LIBRE PARIS SEGMENT OF EURONEXT

 

At the request of InnovaDerma, trading on Marché Libre Paris segment of Euronext for the under-mentioned securities has been suspended from 7 September 2016 pending an application to delist its shares. The Company successfully listed its entire issued share capital consisting of 10,318,535 ordinary shares of €0.10 each (the "Ordinary Shares") on the standard segment of the Official List of the UK Listing Authority to trading on the Main Market for listed securities of the London Stock Exchange on 7 September 2016. Trading in the Company's Ordinary Shares will continue on the London Stock Exchange through this time.

 

For information and guidance, InnovaDerma's shareholders should refer to the Company's Frequently Asked Questions section of its website at www.innovaderma.com/investor-relations-faq/. A further update will be provided when appropriate.

 

Further enquiries

 

InnovaDerma

Haris Chaudhry/Joe Bayer

 

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce/Niall Pearson

 

+44 (0)203 764 2341 / 2343

Cardew Group

Shan Shan Willenbrock

David Roach

Emma Ruttle

 

 

+44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC specialises in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

 

www.innovadermaplc.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKCDBDBKDACK